The Netherlands-based European life sciences investment group, LSP (Life Sciences Partners) has raised $280m for its fifth life sciences venture fund, in an over-subscribed final closing that benefited from family office interest.
The sum raised at final closing was more than $100m over LSP 5’s target figure of $170m, with LSP’s managing...







